Double Malignancies: A Rare Entity
Volume 1 - Issue 1
Subhashish Das*
-
Author Information
Open or Close
- MD, Professor of Pathology, Sri Devaraj Urs Medical College, Inida
*Corresponding author:
Subhashish Das, Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs University,
Tamaka, Kolar, India
Received: April 30, 2018; Published: May 03, 2018
DOI: 10.32474/SCSOAJ.2018.01.000104
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Patients which have diagnosed with a cancer, have a life time
risk for developing another de novo malignancy depending on
various inherited environmental and iatrogenic risk factors. Cancer
victims could survive longer due to settling treatment modalities,
and then would likely develop a new metachronous malignancy
[1]. The incidence of multiple primary malignancies has not been
rare at all. Screening procedures have especially been useful
for the early detection of associated tumors, whereas careful
monitoring of patients has treated for primary cancer, and then
a good communication between patients and medical care team
would certify not only an early detection for secondary tumors,
but only finally & subsequently, an appropriate management [2].
Abbreviations: MPM: Multiple Primary Malignancies; SEER: Surveillance Epidemiology and End Results Programme; SPT: Second
Primary Tumor; TT: Third Tumor; QT: Quadrant Tumor; SPM: Second Primary Malignancies; NAACCR: North American Association
of Central Cancer Registries
Introduction|
Conclusion|
References|